Pharmacokinetics of single-dose primaquine in patients with chronic kidney dysfunction
Author(s) -
NithyaJ Gogtay,
ShaunakP Kulkarni,
SanjanaR Shah,
PrashantP Kadam,
Kannan Sridharan,
NivruttiK Hase,
ParthaP Shetty,
UrmilaM Thatte
Publication year - 2013
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.114997
Subject(s) - primaquine , pharmacokinetics , medicine , renal function , kidney disease , dialysis , pharmacology , gastroenterology , urology , immunology , malaria , chloroquine
The pharmacokinetics of primaquine has not been studied in special populations. Being a basic compound, preferential binding to alpha-1 acid glycoprotein and substrate for P-glycoprotein, may predispose the drug for an altered pharmacokinetics in states of renal dysfunction. This study attempts to evaluate the pharmacokinetics of a single oral dose (15 mg) of primaquine in severely impaired renal function and end stage renal dysfunction patients compared to healthy participants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom